Australia markets close in 3 hours 9 minutes

Rhythm Pharmaceuticals Inc (1RV.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
40.35+1.02 (+2.59%)
At close: 07:02PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
77,428
77,428
23,638
3,154
0
Cost of revenue
9,302
9,302
2,133
599
0
Gross profit
68,126
68,126
21,505
2,555
0
Operating expenses
Research development
134,951
134,951
108,630
104,128
90,450
Selling general and administrative
117,532
117,532
92,032
68,486
46,125
Total operating expenses
252,483
252,483
200,662
172,614
136,575
Operating income or loss
-184,357
-184,357
-179,157
-170,059
-136,575
Interest expense
13,892
13,892
5,201
0
0
Total other income/expenses net
190
190
-790
100,000
-
Income before tax
-184,114
-184,114
-181,119
-69,612
-133,996
Income tax expense
564
564
0
0
-
Income from continuing operations
-184,678
-184,678
-181,119
-69,612
-133,996
Net income
-184,678
-184,678
-181,119
-69,612
-133,996
Net income available to common shareholders
-184,678
-184,678
-181,119
-69,612
-133,996
Basic EPS
-3.24
-
-3.47
-1.40
-3.04
Diluted EPS
-3.24
-
-3.47
-1.40
-3.04
Basic average shares
56,952
-
52,121
49,600
44,127
Diluted average shares
56,952
-
52,121
49,600
44,127